Tianyin Pharmaceutical (TPI) Reports Q1 Earnings of $0.05; Guides FY11 Revs
Tweet
Share
E-mailGet Alerts TPI Hot Sheet
Join SI Premium – FREE
Tianyin Pharmaceutical (NYSE: TPI) reported Q1 EPS of $0.05, versus $0.11 reported last year. Revenue for the quarter came in at $17.5 million, versus $22 million reported last year.
Sees FY2012 revenue of $100 million, versus the consensus of $100.20 million.
Sees FY2012 revenue of $100 million, versus the consensus of $100.20 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
